Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Safer Drugs for Malaria in U.S. Troops, Civilian Personnel, and Travelers: Clinical Evaluation of Primaquine Enantiomer

NCT02898779 is registered in ClinicalTrials.gov with University of Mississippi, Oxford as lead sponsor.

NCT NCT02898779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02898779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Safer Drugs for Malaria in U.S. Troops, Civilian Personnel, and Travelers: Clinical Evaluation of Primaquine Enantiomer
Lead sponsor
University of Mississippi, Oxford
Phase
Phase 1
Overall status
Completed
Start date
May 1, 2017
Completion date
March 1, 2018
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria